Lobektomi Life Saving pada Hemoptisis Berulang pada Tuberkulosis Paru
[Hemoptysis in Aspergiloma Patient: A Case Report]
Background. Hemoptysis is the most common complication of lung tuberculosis (TB). Its can occur repeated and massive. Reccurent massive hemoptysis resolved with conservative therapy but if conservative therapy fails, definitive therapies such as lobectomy surgery are used as alternative treatments especially life-threatening. Case. A 38-year-old man with chief complaint hemoptysis since 4 months pior to admission hospital. Hemoptysis 4-5 times daily with volume 200-600 cc per day and make him shortness of breath and anemia. Initial AFB (Acid Fast Bacilli) was positive and GeneXpert MTB (+) sensitive rifampisin. He got Anti Tuberculosis Drug (ATD) therapy 1st category since 3 months ago. He has been given conservative therapy for hemoptysis but failed. Discussion. Surgery is one of alternative therapy for reccurent massive hemoptysis. Surgery only if source of bleeding already known certainty. In this case patient were suggest for lobectomy superior right lung lobe, not a segmentectomy because there was adhesions on intrathoracic. After lobectomy he getting better and hemoptysis stops. He has continued ATD until 6 months without hemoptysis. Conclusion. Reccurent massive hemoptysis and life-threatening with failure of conservative therapy may given definitive therapy such as lobectomy.
Anonymous. Profil kesehatan Provinsi Jawa Timur 2015. Dinkes Jawa Timur. 2015.; 23-26
Weinberger SE, Lipson DA. Cough and hemoptysis. In: Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison’s Principles of Internal Medicine. 17th New York, NY: McGraw-Hill; 2008:225-228.
Cahill BC, Ingbar DH. Massive hemoptysis. Assessment and management. Clin Chest Med 2012; 15: 147–67.
Corey R, Hla KM. Major and massive hemoptysis: reassessment of conservative management. Am J Med Sci 1997; 294: 301–9
Yi Zhang, MD, PhD, Chang Chen, MD, PhD, and Ge-ning Jiang, MD. Surgery of massive hemoptysis in pulmonary tuberculosis: Immediate and long-term outcomes. The Journal of Thoracic and Cardiovascular Surgery.2014. Volume 148, Number 2
Conlan AA, Hurwitz SS, Krige L, Nicolaou N, Pool R. Massive hemoptysis. Review of 123 cases. J Thorac Cardiovasc Surg 1;85: 120–4.
Semih Halezeroğlu, Erdal Okur. Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach? J Thorac Dis 2014;6(3):182-185.
Azizollah Abbasi Dezfouli, Abolghasem Daneshvar Kakhki, Roya Farzanegan et all. Results of Lobectomy and Pneumonectomy in Pulmonary TB. Tanaffos 2005; 2(7): 33-39
Lee TW, Wan S, Choy DK, Chan M, Arifi A, Yim AP. Management of massive hemoptysis: a single institution experience. Ann Thorac Cardiovasc Surg 2000; 6: 232–5.
Kenneth L. Mattox, M.D., and Gene A. Guinn, M.D. Emergency Resection for Massive Hemoptysis. J. Thoruc.Curdiovusc. Surg.2012. 62:411.
Shouyong Tan, Danxiong Sun, Tiantuo Zhang et all. Risk Factors for Hemoptysis in Pulmonary Tuberculosis Patients from Southern China: A Retrospective Study. Journal of Tuberculosis Research, 2014, 2, 173-180
Liu SF, Lee TY, Wong SL, Lai YF, Lin AS. Transient cortical blindness: a complication of bronchial artery embolization. Respir Med 2012; 92:983–986.
Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care: assessment and management of massive hemoptysis. BMJ Thorax.2003:58: 814-9.
Spinu C, Gonzalez EC, Andreu M, Gallardo X, Duaso MM, Bustelo JC. (2013). Life threatening hemoptysis: role of MDCT angiography. European Society of Radiology. p.1-25.
Agmy GM, Wafy SM, Mohamed SA, Gad YA, Mustafa H, El-Aziz AE. Bronchial and nonbronchial systemic artery embolization in management of Hemoptysis: experience with 348 patients. ISRN VascularMedicine, 2013: 1-5.
Sopko DR, Smith TP. Bronchial artery embolization for hemoptysis. Seminar in Interventional Radiology.2011: 28: 42-62.
Sidhu M, Wieseler K, Burdick TR, Shaw DW. Bronchial artery embolization for hemoptysis. Seminar in Interventional Radiology.2003: 25(3): 310
Copyright (c) 2020 Soedarsono Soedarsono, Tri Puji Astuti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.